Patent US3094388A successfully refreshed from Google Patents.
Patent EP0136490A2 successfully refreshed from Google Patents.
← Back to Patent Explorer
EP0136490A2 Expired / Lapsed EP ⏱️ 0.0 years remaining

DNA plasmids

Assignee: Amgen Inc
•
Filing: 1984-08-10
•
Granted: —
•
Expires: 2004-08-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Disclosed are novel circular DNA plasmids useful as vectors in recombinant methods to secure high levels of E. coli expression of exogenous genes. Plasmids of the invention comprise discrete DNA sequences operative to: (1) confer upon the plasmid the capacity for autonomous replication in a host cell; (2) control autonomous plasmid replication in relation to the temperature at which host cell cultures are maintained; (3) stabilize maintenance of the plasmid in host cell populations; (4) direct synthesis of a protein product indicative of plasmid maintenance in a host cell population; (5) provide, in series, a plurality of restriction endonuclease recognition sites, unique to the plasmid and facilitative of exogenous gene DNA sequence insertion; and (6) terminate mRNA transcription of adjacent DNA sequences and situated so as to terminate transcription of exogenous gene sequences inserted within the plasmid at said unique restriction endonuclease restriction sites. Plasmids preferably have a size of less than 5.0 kilobases (exclusively of any inserted exogenous gene) and optionally include a DNA sequence operative to provide a strong promoter of mRNA transcription functionally associated with a temperature sensitive repressor sequence. A presently preferred embodiment of novel plasmids of the invention is plasmid pCFM414 (A.T.C.C. No. 40076).

Inventors

  • 👤 Charles F. Morris

Bibliographic Details

Application Number —
Jurisdiction EP
Data Source google_patents
Last Synchronized 2026-10-31 13:40
CPC Classifications
C; C12; C12N; C12N15/00; C12N15/09; C12N15/63; C12N15/67; C12N15/69; C07; C07K; C07K14/00; C07K14/435; C07K14/475; C07K14/485; C07K14/52; C07K14/555; C07K14/56; C07K14/575; C07K14/65; C12N15/70; C12N15/73

Claims Analysis

Total Claims: 28
Claim 1
Independent Claim 108 words
1 . A circular DNA plasmid for use as a transformation vector in recombinant methods to secure E .coli expression of exogenous genes, said plasmid comprising discrete DNA sequences operative to: (1) confer upon the plasmid the capacity for autonomous replication in a host cell; (2) control autonomous plasmid replication in relation to the temperature at which host cell cultures are maintained; (3) stabilize maintenance of the plasmid in host cell populations; (4) direct synthesis of a protein product indicative of plasmid maintenance in a host cell population; (5) provide, in series a plurality of restriction endonuclease recognition sites unique to the plasmid; and (6) terminate mRNA transcription.
Claim 2
Dependent Claim 108 words
1 . A circular DNA plasmid for use as a transformation vector in recombinant methods to secure E .coli expression of exogenous genes, said plasmid comprising discrete DNA sequences operative to: (1) confer upon the plasmid the capacity for autonomous replication in a host cell; (2) control autonomous plasmid replication in relation to the temperature at which host cell cultures are maintained; (3) stabilize maintenance of the plasmid in host cell populations; (4) direct synthesis of a protein product indicative of plasmid maintenance in a host cell population; (5) provide, in series a plurality of restriction endonuclease recognition sites unique to the plasmid; and (6) terminate mRNA transcription.
Claim 3
Dependent Claim 31 words
A plasmid according to claim 1 further including a promoter of mRNA transcription at a locus adjacent said DNA sequence operative to provide a plurality of unique restriction endonuclease recognition sites.
Claim 4
Dependent Claim 18 words
A plasmid according to claim 2 wherein the promoter of RNA transcription is a lambda P L promoter.
Claim 5
Dependent Claim 22 words
A plasmid according to claim 2 further including a thermally responsive repressor DNA sequence functionally associated with said promoter of mRNA transcription.
Claim 6
Dependent Claim 12 words
A plasmid according to claim 1 comprising Eewer than 5,000 base pairs.
Claim 7
Dependent Claim 7 words
D N A plasmid pCFM414, A.T.C.C. 40076.
Claim 8
Dependent Claim 7 words
D N A plasmid pCFM414, A.T.C.C. 40076.
Claim 9
Dependent Claim 3 words
DNA plasmid pCFM424.
Claim 10
Dependent Claim 3 words
DNA plasmid pCFM424.
Claim 11
Dependent Claim 3 words
DNA plasmid pCFM510
Claim 12
Dependent Claim 3 words
DNA plasmid pCFM510
Claim 13
Dependent Claim 3 words
DNA plasmid pCFM511.
Claim 14
Dependent Claim 3 words
DNA plasmid pCFM511.
Claim 15
Dependent Claim 3 words
DNA plasmid pCFM512.
Claim 16
Dependent Claim 3 words
DNA plasmid pCFM512.
Claim 17
Dependent Claim 3 words
DNA plasmid pCFM516.
Claim 18
Dependent Claim 3 words
DNA plasmid pCFM516.
Claim 19
Dependent Claim 3 words
DNA plasmid pCFM526.
Claim 20
Dependent Claim 3 words
DNA plasmid pCFM526.
Claim 21
Dependent Claim 3 words
DNA plasmid pCFM536.
Claim 22
Dependent Claim 3 words
DNA plasmid pCFM536.
Claim 23
Dependent Claim 3 words
DNA plasmid pCFM636.
Claim 24
Dependent Claim 3 words
DNA plasmid pCFM636.
Claim 25
Dependent Claim 3 words
DNA plasmid pCFM736.
Claim 26
Dependent Claim 3 words
DNA plasmid pCFM736.
Claim 27
Dependent Claim 3 words
DNA plasmid pCFM836.
Claim 28
Dependent Claim 3 words
DNA plasmid pCFM836.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag